Low sexual desire in women is remarkably common and almost always has more than one cause. Hormones, stress, sleep, medications, relationship dynamics, and physical discomfort during sex can all suppress libido independently or, more often, in combination. The good news is that most of these factors are modifiable. Here’s what actually works, based on what the research shows.
Why Female Desire Drops in the First Place
Sexual desire in women runs on a complicated interplay of hormones, neurotransmitters, and blood flow, all filtered through psychological and relationship context. Estrogen and androgens (including testosterone) influence the brain’s receptivity to sexual cues and regulate blood flow to genital tissue. When these hormones shift, as they do during menstrual cycles, postpartum, perimenopause, and menopause, desire often shifts with them.
But hormones are only part of the picture. Fatigue, stress, body image, unresolved conflict with a partner, and certain medications (especially antidepressants) can each independently flatten desire. This is why there’s no single fix. The most effective approach is identifying which factors are dragging your libido down and addressing them together.
How Sleep Directly Affects Desire
One of the simplest and most overlooked factors is sleep. A study from the University of Michigan tracked women’s sleep and sexual response over 14 days and found that each additional hour of sleep was associated with significantly higher sexual desire the following day. Women who slept longer were also more likely to engage in partnered sexual activity.
This isn’t just about being “less tired.” Sleep regulates the hormones and neurotransmitters that govern arousal. If you’re chronically getting six hours or less, improving your sleep may produce a noticeable difference in desire within a couple of weeks, without any other changes.
Exercise Timing Matters
Physical activity boosts sexual arousal through activation of the sympathetic nervous system, the same system that governs your heart rate and alertness. Research from the University of Texas at Austin found that moderate exercise increased physiological sexual arousal in women, but the timing was specific. Arousal was actually suppressed immediately after exercise, then facilitated at 15 and 30 minutes post-exercise. So the optimal window for sexual activity is roughly 15 to 30 minutes after a workout, not during the post-exercise crash or hours later.
The relationship between exercise intensity and arousal follows a curve: moderate activation produced the greatest arousal response, while both low and high-intensity exercise were less effective. A brisk 20-to-30-minute walk, a moderate cycling session, or a yoga class hits the sweet spot better than an exhausting high-intensity workout. Yoga specifically has shown benefits for sexual function in open-label trials, likely through a combination of nervous system regulation and improved body awareness.
Medications That Lower Libido
SSRIs and other serotonin-based antidepressants are one of the most common causes of low desire in women. If your libido dropped noticeably after starting an antidepressant, the medication is a likely contributor. The strongest evidence for reversing this effect supports adding a second medication that works on dopamine pathways. Switching to an antidepressant with minimal sexual side effects is another well-studied option. Several antidepressants, including bupropion, mirtazapine, agomelatine, and vilazodone, cause little to no sexual suppression compared to placebo.
Dose reduction is considered the least disruptive first step and is worth discussing with your prescriber, particularly if you’re responding well to your current medication otherwise. Exercise before sexual activity has also been shown to improve arousal specifically in women taking SSRIs.
Birth control pills can also dampen desire in some women by increasing a protein that binds up free testosterone. If you noticed a change after starting hormonal contraception, a non-hormonal method or a different formulation may help.
Menopause, Pain, and Vaginal Dryness
For many women over 45, the biggest barrier to desire isn’t a lack of mental interest but physical discomfort. Vaginal atrophy, now called genitourinary syndrome of menopause, causes dryness, thinning tissue, and pain during sex. When sex hurts, your brain learns to avoid it, and desire drops as a protective response. Treating the discomfort often restores desire indirectly.
Non-hormonal options include vaginal moisturizers used every few days (not just during sex), water- or silicone-based lubricants applied before intercourse, vaginal dilators to gently stretch and stimulate the tissues, and topical lidocaine applied to the vaginal opening 5 to 10 minutes before sex to reduce pain. Pelvic floor physical therapy can also help if symptoms are significant.
Hormonal options work more directly on the tissue itself. Low-dose vaginal estrogen, available as a suppository, ring, or tablet, delivers estrogen locally with minimal systemic absorption. DHEA vaginal inserts (prasterone) are another option used nightly for moderate to severe symptoms. For women with a history of estrogen-sensitive breast cancer, ospemifene is an oral option that relieves painful sex without vaginal estrogen. If vaginal dryness accompanies hot flashes and other systemic menopause symptoms, systemic estrogen therapy through pills, patches, or gel addresses everything at once.
Testosterone Therapy for Postmenopausal Women
Testosterone plays a role in female desire, and levels decline naturally with age. Most available evidence supports transdermal testosterone (a cream or patch applied to the skin) for treating low desire in postmenopausal women specifically. Injections, pellets, and oral testosterone are not recommended because they can push levels too high and increase the risk of side effects.
A few important caveats: testosterone levels in blood tests don’t reliably predict who will respond to treatment. If your testosterone is already in the mid-to-high range, the problem is likely elsewhere, and adding more won’t help. Testosterone therapy is not currently recommended for premenopausal women due to insufficient evidence. For postmenopausal women who try it, levels should be checked 3 to 6 weeks after starting and then every 4 to 6 months to ensure they stay within the normal premenopausal range.
FDA-Approved Medications for Low Desire
Two prescription medications are specifically approved for low sexual desire in premenopausal women. Flibanserin (Addyi) is a daily pill taken at bedtime. It works on brain chemistry rather than hormones, affecting serotonin and dopamine signaling. The most common side effects are dizziness, sleepiness, and nausea, and you cannot drink alcohol while taking it due to a risk of severe low blood pressure and fainting. It typically takes several weeks of daily use before effects become apparent.
Bremelanotide (Vyleesi) works differently. It’s a self-administered injection given at least 45 minutes before anticipated sexual activity, used as needed rather than daily. It activates pathways in the brain involved in sexual response. Nausea is the most common side effect, particularly after the first injection.
Neither medication produces dramatic results. In clinical trials, women taking these medications reported modestly more satisfying sexual events per month than those on placebo. They work best as part of a broader approach that includes addressing psychological and relationship factors.
Supplements With Some Evidence
Fenugreek extract has been studied in doses of 500 to 1,000 mg per day, split into two doses, for 6 to 13 weeks, primarily for menopausal symptoms including sexual function. Some trials suggest modest improvements, though the evidence is far less robust than for hormonal or pharmaceutical treatments. Maca root is another commonly recommended supplement, but high-quality randomized controlled trial data in women remains limited.
Supplements are not regulated to the same standard as medications, so quality varies widely between brands. If you try one, give it at least 6 to 8 weeks at a consistent dose before evaluating whether it’s making a difference.
Psychological and Relationship Factors
Desire doesn’t operate in a vacuum. Stress, anxiety, depression, body image concerns, and unresolved tension with a partner are among the most potent suppressors of sexual interest. For many women, desire is “responsive” rather than “spontaneous,” meaning it emerges in response to arousal rather than preceding it. Understanding this pattern can reduce the pressure of waiting to feel desire before initiating intimacy.
Couples therapy or sex therapy can be particularly effective when relationship issues are central. Cognitive behavioral therapy has evidence for addressing the anxiety and avoidance patterns that build up around sex over time. Mindfulness-based interventions, which teach present-moment awareness during sexual experiences, have shown meaningful improvements in desire and arousal in clinical studies. These approaches work well alongside any of the physical or hormonal strategies above, and for some women they’re the most important piece of the puzzle.